DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Emens LA, Cruz C, Braiteh FS. et al.
Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer.
JAMA Oncol 2018;
5: 74-82
doi:10.1001/jamaoncol.2018.4224
We do not assume any responsibility for the contents of the web pages of other providers.